PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin (Q38315381)

2 September 2017

title

PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin (English)

1 reference

2 September 2017

Gang Li

1

1 reference

2 September 2017

Yingchun Hu

2

1 reference

2 September 2017

Yanying Huo

3

1 reference

2 September 2017

Minli Liu

4

1 reference

2 September 2017

Dan Freeman

5

1 reference

2 September 2017

Jing Gao

6

1 reference

2 September 2017

Xin Liu

7

1 reference

2 September 2017

De-Chang Wu

8

1 reference

2 September 2017

Hong Wu

9

1 reference

2 September 2017

language of work or name

English

0 references

publication date

28 February 2006

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

281

1 reference

2 September 2017

issue

16

1 reference

2 September 2017

page(s)

10663-10668

1 reference

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Human cancer, PTEN and the PI-3 kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Amine-modified random primers to label probes for DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Midkine and pleiotrophin in neural development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Profiling the downstream genes of tumor suppressor PTEN in lung cancer cells by complementary DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Profiling of genes expressed by PTEN haploinsufficient neural precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Inhibition of neuronal phenotype by PTEN in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

The lysine-rich C-terminal tail of heparin affin regulatory peptide is required for mitogenic and tumor formation activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Heparin affin regulatory peptide: a new target for tumour therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512509200

21 January 2018

Identifiers

DOI

10.1074/JBC.M512509200

1 reference

2 September 2017

1 reference